Literature DB >> 14595045

Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center.

Annick Galetto-Lacour1, Samuel A Zamora, Alain Gervaix.   

Abstract

OBJECTIVE: To assess the value of bedside tests for predicting the occurrence of severe bacterial infections (SBIs) in children with fever without source.
METHODS: We conducted a prospective study of 99 children, aged 7 days to 36 months, who were seen for fever >38 degrees C and no localizing sign of infection at the emergency department of the University Children's Hospital of Geneva. Blood procalcitonin (PCT), C-reactive protein (CRP), and interleukin-6 (IL-6) values were determined using rapid tests and were compared with the total white blood cell (WBC) count with differential and clinical score. Specificity, sensitivity, predictive values, and multilevel likelihood ratios (LRs) with posttest probabilities of disease were calculated.
RESULTS: Twenty-nine (29%) children received a diagnosis of having an SBI. PCT had the best sensitivity (93%) and negative predictive value (96%). Band count had the best specificity (93%), but its positive predictive value was only 38%. Multilevel LRs revealed that a PCT concentration <0.5 ng/mL (LR: 0.093) almost ruled out SBI (posttest probability of disease: 3.7%) in 54 (54%) subjects, whereas a value >2 ng/mL (LR: 5.2) increased the probability of SBI to 68% in 19 (19%) children. For CRP, values <40 mg/L (LR: 0.263) and >100 mg/L (LR: 14.483) generated posttest probabilities for SBI of 9.7% (61 subjects) and 86.5% (14 subjects), respectively. For WBC count, the posttest probabilities of SBI were modestly changed from the pretest prevalence.
CONCLUSIONS: PCT and CRP performed better than IL-6, WBC, and/or band count in predicting the occurrence of SBI. PCT and CRP bedside tests may be useful tools for emergency and private practice doctors and should be considered in the initial work-up of children with fever without source.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595045     DOI: 10.1542/peds.112.5.1054

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  38 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

2.  Is there a place for "drive thru" management of neonatal fever? Not yet!

Authors:  P Rudd
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01       Impact factor: 5.747

Review 3.  How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus?

Authors:  Nitin Maheshwari
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

4.  Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome.

Authors:  Takao Yoshihara; Toshihiko Imamura; Kentaro Yokoi; Mayumi Shibata; Gen Kano; Shinya Osone; Kanae Yagi; Shinjiro Todo; Yumi Murakami; Yuichi Yamada; Hiroyuki Yamada; Shinji Satomura; Hiroyuki Ishida
Journal:  Eur J Pediatr       Date:  2006-09-30       Impact factor: 3.183

Review 5.  In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?

Authors:  David Herd
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

6.  Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates.

Authors:  Z Reshi; M Nazir; W Wani; M Malik; J Iqbal; S Wajid
Journal:  J Perinatol       Date:  2017-05-25       Impact factor: 2.521

7.  Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.

Authors:  M Sato; H Nakasone; K Terasako-Saito; K Sakamoto; R Yamazaki; Y Tanaka; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; Y Ishihara; K Kawamura; M Ashizawa; S-i Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

8.  Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions.

Authors:  Raymond Oppong; Mark Jit; Richard D Smith; Christopher C Butler; Hasse Melbye; Sigvard Mölstad; Joanna Coast
Journal:  Br J Gen Pract       Date:  2013-07       Impact factor: 5.386

9.  Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial.

Authors:  Sabine Faesch; Bogdan Cojocaru; Carole Hennequin; Stéphanie Pannier; Christophe Glorion; Bernard Lacour; Gérard Chéron
Journal:  Ital J Pediatr       Date:  2009-11-04       Impact factor: 2.638

10.  Applying Ockham's razor to pancreatitis prognostication: a four-variable predictive model.

Authors:  Austin L Spitzer; Anthony M Barcia; Michael T Schell; Annabel Barber; James Norman; James Grendell; Hobart W Harris
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.